Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.

…, S Tomita, A Nakachi, H Miyazato, H Shimoji… - Hepato …, 2002 - europepmc.org
BACKGROUND/AIMS: Genetic alterations are considered to play an important role in both
the carcinogenesis and biological behavior of human malignancies. However, the clinical …

Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma

T Isa, T Kusano, H Shimoji, Y Takeshima, Y Muto… - The American journal of …, 2001 - Elsevier
Background: In order to elucidate the predictive factors for long-term survival in patients with
intrahepatic cholangiocarcinoma (ICC), we evaluated 7 patients who survived for more than …

Induction chemotherapy or chemoradiotherapy followed by radical esophagectomy for T4 esophageal cancer: results of a prospective cohort study

H Shimoji, H Karimata, M Nagahama… - World journal of surgery, 2013 - Springer
Background We hypothesized that the survival rate of patients undergoing R0 esophagectomy
after induction chemotherapy or chemoradiotherapy for unresectable T4 esophageal …

Granular cell tumor of the rectum: a case report and review of the literature

A Nakachi, H Miyazato, T Oshiro, H Shimoji… - Journal of …, 2000 - Springer
A 47-year-old Japanese woman with a 5-year history of alcoholism was admitted to the
Ryukyu University Hospital for the treatment of the alcoholism. For evaluation of observed …

Primary malignant melanoma of the esophagus arising from a melanotic lesion: report of a case

T Oshiro, H Shimoji, F Matsuura, N Uchima, F Kinjo… - Surgery Today, 2007 - Springer
We herein report a case of primary esophageal malignant melanoma in which the development
from a preceding benign melanotic lesion and the growing process of the tumor were …

Clinical significance of HIF-1α expression in patients with esophageal cancer treated with concurrent chemoradiotherapy

K Ogawa, I Chiba, T Morioka, H Shimoji… - Anticancer …, 2011 - ar.iiarjournals.org
Aim: We investigated whether hypoxia-inducible factor-1α (HIF-1 α) expression in
pretreatment biopsies of esophageal cancer is predictive of clinical outcome in patients with …

[HTML][HTML] Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy

…, K OGAwA, T Morioka, H SHIMOjI… - Oncology …, 2011 - spandidos-publications.com
This study aimed to investigate whether glucose transporter-1 (GLUT-1) expression in a
pretreatment esophageal cancer biopsy was predictive of clinical outcomes in patients with …

[PDF][PDF] Recent changes and the future roles of esophageal cancer surgery

T Nishimaki, H Shimoji, H Sunagawa - Ann Thorac Cardiovasc Surg, 2004 - atcs.jp
An esophagectomy remains the mainstay treatment for esophageal cancer, and an R0
resection is the most important type of surgery performed with a curative intent. Although a …

[HTML][HTML] Acute phlegmonous esophagitis as a rare but threatening complication of chemoradiotherapy: report of a case

…, T Nishimaki, A Oshita, M Nagahama, H Shimoji… - Surgery Today, 2014 - Springer
Phlegmonous infection involving the digestive tract has been reported to have a poor
prognosis. However, the pathogenesis and clinical features of acute phlegmonous esophagitis …

Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction …

H Karimata, H Shimoji, T Nishimaki - Surgery Today, 2015 - Springer
Purpose To identify clinicopathological factors predicting R0 resection and long-term
survival after esophagectomy in patients with T4 esophageal cancer following induction …